GenePeeks names new chair
This article was originally published in Scrip
Executive Summary
Lifeprint Group, the parent company for GenePeeks – a genetic information company focused on next-generation disease risk analysis – has named Mara Aspinall executive chair of its board of directors. Ms Aspinall is the former president and CEO of Ventana Medical Systems. Vertana is a member of the Roche Group and a leader in the development, manufacture and commercialization of tissue-based cancer diagnostics that enable the delivery of personalized healthcare to patients. Previously, Ms Aspinall spent 12 years with Genzyme, where she held leadership roles that included president of Genzyme Genetics and president of Genzyme Pharmaceuticals.